股票 › TSHA
泰莎基因治疗 TSHA
美股市值排名 #2991
$4.33 +$0.24 (+5.87%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $4.33 0.00%
开盘$4.16
昨收$4.09
当日区间$4.14 – $4.45
成交量3.18M
市值$1.41B
市盈率（TTM）–
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例93.9%-5.15 个百分点，较上季度
持仓机构数250+1 ，较上季度
内部人近期交易25次买入 / 25次卖出持平
空头持仓比例15.73% 占流通股回补天数 11.6 · 截至 15 Oct 2026
卖空成交量占比24.9%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$3.19M（11个净流入日，9个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有33.8%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从14.60%升至15.73%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| MPM BioImpact LLC | VC/PE Fund | 2026/Q3 | +4,500,000 | 1.4% |
| Wellington Management Group | Mutual Fund | 2026/Q3 | +3,349,244 | 1.2% |
| Pictet Asset Management Limited | Mutual Fund | 2026/Q3 | +2,751,383 | 0.9% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +2,613,106 | 4.4% |
| BlackRock | Mutual Fund | 2026/Q3 | +2,326,319 | 6.4% |
| Farallon Capital Management, L.L.C. | Hedge Fund | 2026/Q3 | +2,250,000 | 0.7% |
| Avoro Capital Advisors LLC | Hedge Fund | 2026/Q3 | +2,188,888 | 7.3% |
| OrbiMed Advisors LLC | VC/PE Fund | 2026/Q3 | +2,000,000 | 0.6% |
| Heights Capital Management, Inc. | VC/PE Fund | 2026/Q3 | +1,500,000 | 0.5% |
| Vestal Point Capital, LP | Hedge Fund | 2026/Q3 | +1,415,000 | 6.0% |
| abrdn plc | Mutual Fund | 2026/Q3 | +1,306,089 | 0.7% |
| Citadel Advisors LLC | Hedge Fund | 2026/Q3 | +1,124,152 | 0.5% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +1,117,511 | 1.0% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +1,028,439 | 2.0% |
| Artal Group S.A. | VC/PE Fund | 2026/Q3 | +1,016,666 | 3.0% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 9 Jul 2026 | Sukumar Nagendran | President, Head of Research & Development and Director | Automatic Disposition | -200,000 | $6.24 | – |
| 31 May 2026 | Phillip Donenberg | Independent Director | Other Acquisition | +21,335 | – | 21,335 |
| 31 May 2026 | Phillip Donenberg | Independent Director | Other Derivative Acquisition | +42,671 | $5.97 | 42,671 |
| 31 May 2026 | Sean Stalfort | Independent Director | Other Acquisition | +21,335 | – | 21,335 |
| 31 May 2026 | Sean Stalfort | Independent Director | Other Derivative Acquisition | +42,671 | $5.97 | 42,671 |
| 31 May 2026 | Laura Sepp-Lorenzino | Independent Director | Other Acquisition | +21,335 | – | 21,335 |
| 31 May 2026 | Laura Sepp-Lorenzino | Independent Director | Other Derivative Acquisition | +42,671 | $5.97 | 42,671 |
| 31 May 2026 | Alison Long | Independent Director | Other Acquisition | +21,335 | – | 21,335 |
| 31 May 2026 | Alison Long | Independent Director | Other Derivative Acquisition | +42,671 | $5.97 | 42,671 |
| 9 Apr 2026 | Sukumar Nagendran | President, Head of Research & Development and Director | Automatic Disposition | -180,979 | $4.46 | 34,227 |
| 9 Apr 2026 | Sukumar Nagendran | President, Head of Research & Development and Director | Derivative Exercise and Sale | -19,021 | $4.46 | 34,227 |
| 26 Feb 2026 | Rumana Haque-Ahmed | Chief Regulatory Officer | Intent to Sell (Form 144) | -2,405 | $4.57 | – |
| 3 Feb 2026 | Sean McAuliffe | Chief Business Officer | Intent to Sell (Form 144) | -914 | $4.72 | – |
| 3 Feb 2026 | Kamran Alam | Chief Financial Officer | Open Market Disposition | -1,655 | $4.52 | 1,442,131 |
| 3 Feb 2026 | Rumana Haque-Ahmed | Chief Regulatory Officer | Intent to Sell (Form 144) | -697 | $4.72 | – |
| 25 Jan 2026 | Sean Nolan | Chairperson & CEO | Open Market Disposition | -178,101 | $4.75 | 638,538 |
| 25 Jan 2026 | Sukumar Nagendran | President, Head of Research & Development and Director | Open Market Disposition | -116,050 | $4.75 | 215,205 |
| 25 Jan 2026 | Kamran Alam | Chief Financial Officer | Open Market Disposition | -102,817 | $4.75 | 1,443,786 |
| 22 Jan 2026 | Sean Nolan | Chairperson & CEO | Intent to Sell (Form 144) | -168,078 | $5.09 | – |
| 22 Jan 2026 | Sukumar Nagendran | President, Head of Research & Development and Director | Intent to Sell (Form 144) | -113,824 | $5.09 | – |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 51,249,292 | 15.7% | 11.6 |
| 30 Sep 2026 | 55,020,663 | 16.9% | 11.2 |
| 15 Sep 2026 | 51,405,384 | 15.8% | 18.8 |
| 31 Aug 2026 | 46,800,424 | 14.4% | 19.4 |
| 14 Aug 2026 | 46,738,149 | 14.3% | 17.4 |
| 31 Jul 2026 | 46,691,810 | 14.6% | 19.0 |
暂无评论——快来第一个聊聊 TSHA。
登录后参与讨论。